Table 1 Demographic data and clinical characteristics of the enrolled subjects.

From: Associations between Antibiotics for Non-tuberculous Mycobacterial Infection and Incident Sjögren’s Syndrome: A Nationwide, Population-based Case-control Study

 

Control

Case

P-value

(n = 83,295)

(n = 5,553)

Age, years (mean ± SD)

55 ± 14

55 ± 14

1

Age group

   

≤40 years

12,690 (15.2)

846 (15.2)

 

40–65 years

50,175 (60.2)

3,345 (60.2)

 

≥65 years

20,430 (24.5)

1,362 (24.5)

 

Gender

  

1

Female

73,365 (88.1)

4,891 (88.1)

 

Male

9,930 (11.9)

662 (11.9)

 

CCI

0.4 ± 1.0

0.5 ± 0.9

<0.001

CCI group

<0.001

0

65,184 (78.3)

3,753 (67.6)

 

≥1

18,111 (21.7)

1,800 (32.4)

 

Bronchiectasis

922 (1.1)

197 (3.6)

<0.001

History of H. pylori infection a

209 (0.3)

52 (0.9)

<0.001

  1. aOne year prior to the index date. Abbreviations: SS, Sjögren’s syndrome; CCI, Charlson comorbidity index; H. pylori, Helicobacter pylori; NA, non-applicable. Percentages are enclosed in parentheses after each value unless otherwise indicated.
Back to article page